Login

Orgenesis Inc. 8-K SEC Filings

Filed On Filing
02 Jun 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

As disclosed below, at the special meeting of Orgenesis, Inc. (the “Company”) held on May 27, 2026 (the “Special Meeting”), the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s Articles of Incorporation, as...

13 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

On March 10, 2026, the Board of Directors (the “Board”) of the Company elected Adam Pelavin and Yaron Adler to serve immediately as members of the Board with a term expiring at the Company’s 2026 annual meeting of stockholders and therea...

26 Jan 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities

THESE SECURITIES WERE ISSUED IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE 1933 ACT) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 AC...

16 Sep 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

This Convertible Loan Agreement (this “Agreement”) is made as of the 10th day of September, 2025 (“Effective Date”), by and among (1) Alpha Prosperity Fund SPC, a segregated portfolio company with limited liability incorporated under the...

25 Aug 2025 8-K: Departure/Election of Directors or Officers; Compensation

On August 21, Ashish Nanda notified Orgenesis Inc. (the “Company”), of his decision to resign as director of the Company, effective immediately. Mr. Nanda’s resignation was not the result of any disagreement with the Company, or its mana...

19 Aug 2025 8-K: Departure/Election of Directors or Officers; Compensation

On August 8, 2025, Mr. Victor Miller, the Chief Financial Officer, Treasurer and Secretary of OrgenesisInc. (the “Company”), resigned effective immediately from all positions he held with the Company to pursue other opportunities. Mr. Mi...

01 Aug 2025 8-K: Other Events

On July 29, 2025, the OTC Markets Group (“OTC Markets”) notified Orgenesis Inc. (the “Company”) that it has determined to move the Company’s common stock from Pink Limited to the Expert Market tier effective immediately.

06 Jun 2025 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On June 2, 2025, the OTC Markets Group (“OTC Markets”) notified Orgenesis Inc. (the “Company”) that it has determined to move the Company’s common stock from OTCQX to the Pink Limited tier effective June 3, 2025.

22 Apr 2025 8-K: Other Events

On April 17, 2025, Orgenesis Inc. (the “Company”) received a notice that is delinquent in filing its 10-K for the period ending December 31st, 2024 and therefore no longer meets the OTCQX Requirements for Continued Qualification as per S...

06 Mar 2025 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets

This Agreement (“Agreement”) is made this 28 day of February, 2025 (“Effective Date”), by and between Orgenesis, Inc., a Nevada corporation, having an address at 20271 Goldenrod Lane, Germantown, MD, 20876 USA (including any affiliate or...

28 Jan 2025 8-K: Entry into a Material Definitive Agreement

THIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is entered into as of January 22, 2025 (the “Execution Date”), by and between Orgenesis Inc, a Nevada corporation (the “Company”), and Williamsburg Venture Holdings, LLC, a Nevada limited...

27 Dec 2024 8-K: Departure/Election of Directors or Officers; Compensation

On December 24, 2024, Jagannathan Bhalaji notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons. Mr. Bhalaji’s resignation was not the result of any d...

05 Nov 2024 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

FOR VALUE RECEIVED, Orgenesis Maryland, LLC, a Maryland limited liability company (the “Borrower”) and wholly-owned subsidiary of Orgenesis Inc. (“Orgenesis”), hereby promises to pay to the order of Jacob Safier, or his successors or ass...

01 Nov 2024 8-K: Departure/Election of Directors or Officers; Compensation

On October 28, 2024, the Board of Directors (the “Board”) of the Company, following the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Adam Pelavin, Jagannathan Bhalaji, and Santhosh Nagaraj to ...

23 Oct 2024 8-K: Departure/Election of Directors or Officers; Compensation

On October 19, 2024, Mark Goodman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons. Mr. Goodman’s resignation was not the result of any disagreem...

17 Oct 2024 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On October 17, 2024, the Nasdaq Stock Market LLC (“Nasdaq”) notified Orgenesis Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s securi...

23 Sep 2024 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

GERMANTOWN, MD, September 23, 2024 – Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s common stock, par value $0.0001, wh...

29 Aug 2024 8-K: Regulation FD Disclosure

A copy of a presentation that is intended to be used by representatives of Orgenesis Inc. (the “Company”) in meetings with prospective investors and other parties, as well as on the Company’s website, is furnished as Exhibit 99.1 to this...

26 Aug 2024 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUA...

14 Aug 2024 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities

This STRATEGIC PARTNERSHIP AGREEMENT (“Agreement”) is entered into on this 9th day of August 2024 (“Effective Date”) by and between Orgenesis, Inc. a Nevada corporation, USA, having an address at 20271 Goldenrod Lane, Germantown ,MD 2087...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support